Mutations in high-risk gene candidates for schizophrenia such as neuregulin 1, DISC1, and dysbindin have all been demonstrated to disturb NMDA receptor regulation (Geddes et al., 2011; Karlsgodt et al., 2011; Ma et al., 2013). The gene discussed is DTNBP1; the disease is schizophrenia.